KURA - Kura Oncology, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
San Diego,
United States
Type: Equity
KURA price evolution
KURA
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jul 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $37.32 | $28.74 | $49.33 | $27.27 |
| Short term investments | $386.64 | $423.85 | $427.86 | $378.84 |
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $432.48 | $459.92 | $485.65 | $416.45 |
| Long term investments | ||||
| Property, plant & equipment | $8.85 | $9.34 | $5.19 | $5.76 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $16.45 | $13.85 | $9.09 | $9.53 |
| Total investments | $386.64 | $423.85 | $427.86 | $378.84 |
| Total assets | $448.94 | $473.77 | $494.74 | $425.98 |
| Current liabilities | ||||
| Accounts payable | $33.76 | $25.84 | $21.55 | $16.9 |
| Deferred revenue | ||||
| Short long term debt | $1.51 | $1.68 | $2.35 | $2.33 |
| Total current liabilities | $35.26 | $27.52 | $23.9 | $19.23 |
| Long term debt | $15.69 | $15.74 | $10.7 | $11.21 |
| Total noncurrent liabilities | $16.4 | $16.31 | $11.16 | $11.56 |
| Total debt | $17.2 | $17.42 | $13.04 | $13.54 |
| Total liabilities | $51.66 | $43.83 | $35.06 | $30.79 |
| Shareholders' equity | ||||
| Retained earnings | -$721.44 | -$678.65 | -$640.05 | -$602.88 |
| Other shareholder equity | -$1.27 | -$3.54 | -$5.22 | -$5.9 |
| Total shareholder equity | $397.27 | $429.94 | $459.68 | $395.18 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $37.32 | $52.01 | $90.88 | $325.7 |
| Short term investments | $386.64 | $386.18 | $427.29 | $307.83 |
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $432.48 | $446.43 | $522.29 | $637.29 |
| Long term investments | ||||
| Property, plant & equipment | $8.85 | $6.38 | $8.25 | $8.36 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $16.45 | $9.88 | $11.76 | $9.92 |
| Total investments | $386.64 | $386.18 | $427.29 | $307.83 |
| Total assets | $448.94 | $456.31 | $534.05 | $647.21 |
| Current liabilities | ||||
| Accounts payable | $33.76 | $1.53 | $22.45 | $23.02 |
| Deferred revenue | ||||
| Short long term debt | $1.51 | $2.32 | $3 | |
| Total current liabilities | $35.26 | $24.06 | $22.45 | $26.02 |
| Long term debt | $15.69 | $9.16 | $4.61 | $9.89 |
| Total noncurrent liabilities | $16.4 | $11.97 | $4.99 | $10.28 |
| Total debt | $17.2 | $14.02 | $4.61 | $12.89 |
| Total liabilities | $51.66 | $36.03 | $27.44 | $36.31 |
| Shareholders' equity | ||||
| Retained earnings | -$721.44 | -$568.81 | -$432.97 | -$302.5 |
| Other shareholder equity | -$1.27 | -$8.03 | -$1.79 | $0.05 |
| Total shareholder equity | $397.27 | $420.28 | $506.61 | $610.9 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jul 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $32.53 | $29.33 | $25.19 | |
| Selling, general & administrative | $14.23 | $13.14 | $11.37 | |
| Total operating expenses | $46.76 | $42.47 | $36.57 | |
| Operating income | -$46.76 | -$42.47 | -$36.57 | |
| Income from continuing operations | ||||
| EBIT | -$42.39 | -$38.2 | -$33.7 | |
| Income tax expense | ||||
| Interest expense | $0.39 | $0.4 | $0.36 | |
| Net income | ||||
| Net income | -$42.79 | -$38.6 | -$34.07 | |
| Income (for common shares) | -$42.79 | -$38.6 | -$34.07 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $115.23 | $92.81 | $84.72 | $60.4 |
| Selling, general & administrative | $50.57 | $47.05 | $46.54 | $31.5 |
| Total operating expenses | $165.8 | $139.87 | $131.26 | $91.9 |
| Operating income | -$165.8 | -$139.87 | -$131.26 | -$91.9 |
| Income from continuing operations | ||||
| EBIT | -$151.08 | -$135.61 | -$130.05 | -$89.05 |
| Income tax expense | ||||
| Interest expense | $1.55 | $0.23 | $0.41 | $0.58 |
| Net income | ||||
| Net income | -$152.63 | -$135.84 | -$130.47 | -$89.63 |
| Income (for common shares) | -$152.63 | -$135.84 | -$130.47 | -$89.63 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$42.79 | -$38.6 | -$37.17 | -$34.07 |
| Operating activities | ||||
| Depreciation | $0.21 | $0.22 | $0.21 | $0.21 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $7.17 | $7.09 | $6.99 | $6.84 |
| Total cash flows from operations | -$34.31 | -$29.03 | -$25.62 | -$35.87 |
| Investing activities | ||||
| Capital expenditures | -$0.02 | -$0.02 | -$0.1 | -$0.04 |
| Investments | $42.21 | $8.58 | -$46.23 | $11.16 |
| Total cash flows from investing | $42.2 | $8.56 | -$46.33 | $11.13 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.69 | $0.08 | $94.01 | |
| Net borrowings | ||||
| Total cash flows from financing | $0.69 | $0.08 | $94.01 | |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $8.58 | -$20.38 | $22.07 | -$24.74 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$152.63 | -$135.84 | -$130.47 | -$89.63 |
| Operating activities | ||||
| Depreciation | $0.85 | $0.76 | $0.56 | $0.19 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $28.08 | $26.32 | $23.58 | $12.81 |
| Total cash flows from operations | -$124.82 | -$110.06 | -$104.55 | -$69.83 |
| Investing activities | ||||
| Capital expenditures | -$0.17 | -$0.63 | -$1.15 | -$2.17 |
| Investments | $15.72 | $33.25 | -$125.69 | -$97.77 |
| Total cash flows from investing | $15.56 | $32.63 | -$126.83 | -$99.94 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $94.78 | $29.14 | $4.43 | $469.58 |
| Net borrowings | $9.43 | -$7.86 | -$0.25 | |
| Total cash flows from financing | $94.78 | $38.56 | -$3.44 | $469.33 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$14.48 | -$38.87 | -$234.82 | $299.57 |
News
Fundamentals
| Market cap | $1.35B |
|---|---|
| Enterprise value | $1.33B |
| Shares outstanding | 74.35M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 3.39 |
| Book/Share | 5.36 |
| Cash/Share | 0.50 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.13 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 12.26 |
| Quick ratio | 12.26 |